Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Other Operating Expenses (2016 - 2023)

Assembly Biosciences (ASMB) has 5 years of Other Operating Expenses data on record, last reported at $41.6 million in Q4 2021.

  • For Q4 2021, Other Operating Expenses changed N/A year-over-year to $41.6 million; the TTM value through Sep 2022 reached $41.6 million, changed N/A, while the annual FY2021 figure was $41.6 million, N/A changed from the prior year.
  • Other Operating Expenses reached $41.6 million in Q4 2021 per ASMB's latest filing, up from $4000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $41.6 million in Q4 2021 and bottomed at -$127000.0 in Q2 2018.
  • Average Other Operating Expenses over 4 years is $4.1 million, with a median of $4.5 recorded in 2017.
  • Peak YoY movement for Other Operating Expenses: crashed 39713.53% in 2018, then soared 104.35% in 2019.
  • A 4-year view of Other Operating Expenses shows it stood at -$372.0 in 2017, then plummeted by 21943.01% to -$82000.0 in 2018, then soared by 104.88% to $4000.0 in 2019, then soared by 1040850.0% to $41.6 million in 2021.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $41.6 million in Q4 2021, $4000.0 in Q2 2019, and $1000.0 in Q1 2019.